Make an appointment by phone
Make an appointment with MyChart
Book with MyChart
Hours of Operation: Monday - Friday 8 a.m. - 5 p.m.
Call for assistance with the referral process
The Department of Rheumatology provides a full range of services - including joint injections, musculoskeletal ultrasound, and infusion therapies – for arthritis and systemic rheumatic autoimmune diseases, including scleroderma, lupus, inflammatory arthritis, spondyloarthritis, osteoarthritis, and gout. For all conditions, our rheumatologists work closely with providers in other departments to ensure you receive the best care possible, for all aspects of your health.
Our department includes specific programs for several conditions, including the largest scleroderma program in New England and a lupus program that offers multidisciplinary care in conjunction with a variety of specialists.
A 正规的滚球平台 clinical pharmacist works closely with our doctors and patients to ensure that you have all the information you need about your medications and that medication interactions are minimized. We can also help you navigate the insurance process, so you can get joint-saving treatment safely and without delay. Our 正规的滚球平台 Infusion Suite provides patients with the utmost privacy, comfort, and convenience.
Our rheumatologists are actively engaged in research and have led development of national treatment guidelines in osteoarthritis, gout, and spondyloarthritis. We provide many opportunities for patients to participate in clinical trials.
Professor of Medicine, Boston University School of Medicine, Boston MA
Rheumatology and Internist
Professor of Medicine and Public Health, Boston University School of Medicine, Boston MA
Rheumatoid Arthritis, Gout, Psoriatic Arthritis, Lupus, Connective Tissue Disease
Scleroderma and connective tissue disease
Other team members
Nancy Figueiredo, RN
Our rheumatology department members have research expertise in many areas of rheumatic diseases. Our faculty are internationally recognized for contributions to research and have been at the forefront of developing new approaches to the study and treatment of disorders such as scleroderma, osteoarthritis, lupus, vasculitis, spondyloarthritis and gout.
Residency and Fellowship Information
Latest from HealthCity
Tuhina Neogi, MD, PhD, and Nina Lin, MD describe their COVID clinical trials and why engaging underrepresented minorities to participate is essential.
HealthCity is Boston Medical Center's online publication that explores the most pressing issues in healthcare. At HealthCity, we believe that healthcare must transform itself to become more equitable, sustainable, and open source.